Garner Health

getgarner.com →

+8%

est. 2Y upside i

HealthcareSeries D+

Garner Health helps employers enrich employee benefits and reduce costs without changing plans or networks.

Rank

#1866

Sector

Health Tech

Est. Liquidity

~3Y

Data Quality

Data: Medium

Garner Health offers strong growth and a data moat, but the current valuation of 13.7x ARR is high.

Last updated: July 19, 2026

Bull (30%)+99%

With strong data moat and potential IPO window, exit multiple could hold at 10x, yielding ~$6.8B exit. Net upside after 20% dilution ~99%.

Base (50%)-20%

Multiple converges toward public comps around 4x, exit ~$2.73B. After dilution, slight downside ~20%.

Bear (20%)-60%

Multiple compresses to 2x due to competition or market saturation, exit ~$1.37B, net downside ~60%.

Est. time to liquidity~3.0 years

Preference Stack Risk

moderate

Funding Intensity

11%

Total funding of $300M represents 11% of current valuation, so preference stack is moderate; common stock recovers zero only if exit value falls below $300M.

Dilution Risk

high

Given $200M ARR and $100M raised, high growth likely requires another raise within 24 months, causing 15-25% dilution.

Secondary Liquidity

none

No secondary market transactions reported; equity liquidity expected only via IPO or acquisition.

View all 76 open roles at Garner Health →

Last updated: September 6, 2026

Questions to Ask at the Interview

Strategic questions based on Garner Health's data — designed to show you've done your homework.

  • 1

    “How does Garner's data moat compare to incumbent data assets like Optum's or CVS's?”

  • 2

    “What is the path to profitability given the high growth spending and 75% gross margin?”

  • 3

    “How does the equity structure (preferred vs common) and liquidation preferences affect employee stock value in various exit scenarios?”

Community

Valuation Sentiment

Our model estimates +8% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.